The global fertility supplements market was valued at USD 2.56 billion in 2025 and is projected to reach USD 4.27 billion by 2032, expanding at a CAGR of 4.27%. Market growth is supported by rising infertility prevalence, delayed parenthood trends, increasing health awareness, and growing adoption of evidence-based nutritional support for reproductive health. Demand remains strong across fertility vitamins, prenatal supplements, and targeted formulations addressing hormonal balance, ovulation support, and sperm health, with natural and clean-label ingredients gaining traction.
Fertility Supplements overview
Published by MMR Statistics Research Team, Updated
